Biotech, articles on Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech, articles on

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jongmans who started this subject	8/12/2000 9:09:35 PM
From: sim1	of 36

Aspirin: The Second Generation Finding Two Enzymes Instead of One Has Opened the Way to New Drugs BY JEAN-PIERRE FALGUEYRET, JACQUES YVES GAUTHIER AND PATRICK J. ROY One of the most widely used classes of medication today are the non-steroidal antiinflammatory drugs (NSAIDs). Their prolonged use, however, can lead to serious, even fatal, side effects. Merck Frosst Canada's scientists J.-P. Falgueyret, J.Y. Gauthier and P.J. Roy describe how a recent discovery has led to the development of new antiinflammatories that will be less damaging over prolonged use. gbhap.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next